Novel neurosteroid anesthetics and developmental synaptogenesis

新型神经类固醇麻醉剂和发育突触发生

基本信息

  • 批准号:
    10673850
  • 负责人:
  • 金额:
    $ 52.82万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-12 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

Summary Exposure of young children to general anesthetics (GAs) is common in medicine; however, emerging data suggest that this practice may be detrimental to brain development, resulting in long-term cognitive impairments. Since currently used GAs known to be neurotoxic to the immature brain exert their action by modulating two main receptor systems – GABA and NMDA – we suggest the general hypothesis that novel anesthetics with different cellular targets might be safe and promising alternative. One such alternative is a family of neuroactive steroids with blocking action on low-voltage-activated T-type calcium channels known to be important for neuronal excitability and synaptic transmission. Our long-term goal is to develop novel GAs that will provide the same reliability and efficacy as currently available ones but without devastating long-term consequences. We are off to a promising start since T-channel-blocking neuroactive steroids are not only powerful analgesics but also effective hypnotics. Most importantly, compared with other injectable (and inhaled) anesthetics, they appear to be much less harmful to the developing brain based on our preliminary pathomorphological and functional findings. Our rationale is that the design of safer anesthetics for use in children should be guided by the presently available understanding of the mechanisms responsible for developmental neurotoxicity of currently used GAs. To that end, we will use ex vivo and in vivo rat models of GA-induced developmental neurotoxicity to address the specific hypothesis that novel neuroactive steroids with blocking action on T-channels, unlike clinically-used GAs, are effective and safe anesthetics for use during critical stages of brain development. Aim #1: Characterizes anesthetic properties of novel neuroactive steroid analogs that are T-channel blockers (e.g. 3-OH and ECN) and GABAA agonists (e.g. ACN, CDNC24 and alphaxalone) and compares their anesthesia profile in rats and mice with commonly used injectable anesthetic, propofol. Preliminary data suggest that 3-OH is safe and effective and, compared with ketamine, it exhibits higher efficacy and potency when administered to rat pups (at post-natal day 7). Aim #2: Examines neurotoxic potential of neuroactive steroid analogs vis-à-vis propofol (known to cause significant developmental neurotoxicity) by focusing on morphological and functional features of GA-induced impairments of synaptogenesis (e.g. acute apoptotic cell death, delayed impairment in synapse formation/maintenance, integrity of mitochondria, neuronal survival and impairment in synaptic transmission). Aim #3: Scrutinizes long- term functional outcomes of an early exposure to novel neuroactive steroid analogs with particular focus on neuronal communication in hippocampal ex vivo slice preparation and in vivo assessment of cognitive development. Our preliminary findings suggest a lack of cognitive impairment after an early exposure to 3- OH. Aim #4: Takes rodent studies to the next level by examining the anesthetic properties and safety of a chosen neuroactive steroid (as determined in Aims 1-3) in infant non-human primates.
总结 幼儿暴露于全身麻醉药(GAs)在医学中很常见;然而, 这表明这种做法可能不利于大脑发育,导致长期的认知障碍。 损伤由于目前使用的已知对未成熟大脑具有神经毒性的GA通过以下方式发挥其作用: 调节两个主要的受体系统- GABA和NMDA -我们提出了一般假设, 具有不同细胞靶点的麻醉剂可能是安全且有前途的替代品。一种这样的替代 是已知对低电压激活的T型钙通道具有阻断作用的神经活性类固醇家族 对神经元的兴奋性和突触传递很重要。我们的长期目标是开发新的遗传算法 这将提供与现有产品相同的可靠性和有效性,但不会造成长期的破坏性影响。 后果我们有一个充满希望的开始,因为T通道阻断神经活性类固醇不仅 强效镇痛药,也是有效的催眠药。最重要的是,与其他注射剂(和 吸入)麻醉剂,它们似乎对发育中的大脑的伤害要小得多, 初步病理形态学和功能发现。我们的基本原理是, 用于儿童的麻醉剂应该以目前对机制的理解为指导, 导致目前使用的GA的发育神经毒性。为此,我们将使用体外和体内 GA诱导的发育神经毒性大鼠模型,以解决新的特定假设, 与临床使用的GA不同,对T通道具有阻断作用的神经活性类固醇是有效和安全的 在大脑发育的关键阶段使用的麻醉剂。目的#1:表征以下物质的麻醉特性 新型神经活性类固醇类似物,其为T-通道阻断剂(例如3-OH和ECN)和GABAA激动剂 (e.g. ACN、CDNC 24和阿法沙酮),并将其在大鼠和小鼠中的麻醉特征与常用的 注射麻醉剂异丙酚初步数据表明,3-羟色胺是安全有效的, 与氯胺酮一起,当给予大鼠幼崽(出生后第7天)时,它表现出更高的功效和效力。目的 #2:检查神经活性类固醇类似物维斯维斯丙泊酚的神经毒性潜力(已知会引起显著的 发育神经毒性)通过关注GA诱导的损伤的形态和功能特征 突触发生(例如急性凋亡性细胞死亡,突触形成/维持中的延迟损伤, 线粒体的完整性、神经元存活和突触传递的损伤)。目标#3:仔细检查长期- 早期暴露于新型神经活性类固醇类似物的长期功能结局,特别关注 海马离体切片制备中神经元通讯和认知功能的体内评估 发展我们的初步研究结果表明,在早期暴露于3毫克- 哦目标#4:通过检查麻醉剂的麻醉特性和安全性,将啮齿动物研究提升到一个新的水平。 选择的神经活性类固醇(如目的1-3中所确定的)。

项目成果

期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Correction to: Benchmarking of Anesthesia and Surgical Control Times by Current Procedural Terminology (CPT®) Codes.
更正:按现行程序术语 (CPT®) 代码对麻醉和手术控制时间进行基准测试。
  • DOI:
    10.1007/s10916-022-01849-5
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    Simmons,ColbyG;Alvey,NicholasJ;Kaizer,AlexanderM;Williamson,Kayla;Faruki,AdeelA;Kacmar,RachelM;Jevtovic-Todorovic,Vesna;Weitzel,NathaenS
  • 通讯作者:
    Weitzel,NathaenS
Neuron-Glia Crosstalk Plays a Major Role in the Neurotoxic Effects of Ketamine via Extracellular Vesicles.
  • DOI:
    10.3389/fcell.2021.691648
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    5.5
  • 作者:
    Penning DH;Cazacu S;Brodie A;Jevtovic-Todorovic V;Kalkanis SN;Lewis M;Brodie C
  • 通讯作者:
    Brodie C
Anesthesia and Cancer, Friend or Foe? A Narrative Review.
麻醉和癌症,朋友还是敌人?叙事评论。
  • DOI:
    10.3389/fonc.2021.803266
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
    Montejano J;Jevtovic-Todorovic V
  • 通讯作者:
    Jevtovic-Todorovic V
Alpha lipoic acid attenuates evoked and spontaneous pain following surgical skin incision in rats.
  • DOI:
    10.1080/19336950.2021.1907058
  • 发表时间:
    2021-12
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Joksimovic SL;Lamborn N;Jevtovic-Todorovic V;Todorovic SM
  • 通讯作者:
    Todorovic SM
Sex hormones and the young brain: are we ready to embrace neuroprotective strategies?
性激素和年轻的大脑:我们准备好接受神经保护策略了吗?
  • DOI:
    10.1016/j.bja.2021.10.032
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    9.8
  • 作者:
    Jevtovic-Todorovic,Vesna
  • 通讯作者:
    Jevtovic-Todorovic,Vesna
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Vesna Jevtovic-Todorovic其他文献

Vesna Jevtovic-Todorovic的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Vesna Jevtovic-Todorovic', 18)}}的其他基金

Anesthesiology Mentored Research Training
麻醉学指导研究培训
  • 批准号:
    10398792
  • 财政年份:
    2021
  • 资助金额:
    $ 52.82万
  • 项目类别:
Anesthesiology Mentored Research Training
麻醉学指导研究培训
  • 批准号:
    10089968
  • 财政年份:
    2021
  • 资助金额:
    $ 52.82万
  • 项目类别:
Anesthesiology Mentored Research Training
麻醉学指导研究培训
  • 批准号:
    10612402
  • 财政年份:
    2021
  • 资助金额:
    $ 52.82万
  • 项目类别:
Novel neurosteroid anesthetics and developmental synaptogenesis
新型神经类固醇麻醉剂和发育突触发生
  • 批准号:
    10201697
  • 财政年份:
    2019
  • 资助金额:
    $ 52.82万
  • 项目类别:
Novel neurosteroid anesthetics and developmental synaptogenesis
新型神经类固醇麻醉剂和发育突触发生
  • 批准号:
    10456624
  • 财政年份:
    2019
  • 资助金额:
    $ 52.82万
  • 项目类别:
Novel neurosteroid anesthetics and developmental synaptogenesis
新型神经类固醇麻醉剂和发育突触发生
  • 批准号:
    10017289
  • 财政年份:
    2019
  • 资助金额:
    $ 52.82万
  • 项目类别:
Novel neurosteroid anesthetics and perioperative analgesia
新型神经类固醇麻醉剂和围手术期镇痛
  • 批准号:
    9333664
  • 财政年份:
    2017
  • 资助金额:
    $ 52.82万
  • 项目类别:
Novel neurosteroid anesthetics and perioperative analgesia
新型神经类固醇麻醉剂和围手术期镇痛
  • 批准号:
    9926278
  • 财政年份:
    2017
  • 资助金额:
    $ 52.82万
  • 项目类别:
Molecular mechanisms of glycosylation of Cav3.2 channels in pain pathway
疼痛通路中Cav3.2通道糖基化的分子机制
  • 批准号:
    9127411
  • 财政年份:
    2016
  • 资助金额:
    $ 52.82万
  • 项目类别:
Molecular mechanisms of glycosylation of Cav3.2 channels in pain pathway
疼痛通路中Cav3.2通道糖基化的分子机制
  • 批准号:
    9471872
  • 财政年份:
    2016
  • 资助金额:
    $ 52.82万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 52.82万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.82万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 52.82万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.82万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 52.82万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.82万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 52.82万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 52.82万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 52.82万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 52.82万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了